PhaseBio Pharmaceuticals, Inc. (PHAS)
Retained Earnings
-$419.60M
Quarterly · Period ending: · USD
PHAS Retained Earnings
Latest reported-$391.79Mperiod ending
Latest reported-$391.79Mperiod ending
PHAS FY Retained Earnings (-$88.82M → -$391.79M)
Annual retained earnings
High-resolution chart · PNG
PHAS retained earnings history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| -391,794,000 | |
| -260,723,000 | |
| -162,158,000 | |
| -122,911,000 | |
| -99,065,000 | |
| -88,818,000 |